Sex differences in smoking cessation: a retrospective cohort study in a psychosocial care unit in Brazil
Carregando...
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2023
Título da Revista
ISSN da Revista
Título do Volume
Editora
ASSOC PSIQUIATRIA RIO GRANDE SUL
Autores
GUIMARAES-PEREIRA, Bruna Beatriz Sales
MARTINS-DA-SILVA, Anderson Sousa
CARVALHO, Carlos Felipe Cavalcanti
LORETO, Aline Rodrigues
GALVAO, Lucas Pequeno
FRALLONARDO, Fernanda Piotto
ISMAEL, Flavia
TORALES, Julio
VENTRIGLIO, Antonio
Citação
TRENDS IN PSYCHIATRY AND PSYCHOTHERAPY, v.45, article ID e20210217, 11p, 2023
Resumo
Introduction: Despite the results of epidemiological and psychometric studies reporting comparable levels of tobacco dependence among males and females, some clinical studies have detected disparities. Some smoking cessation studies based on clinical setting programs reported poorer outcomes among women than men.Methods: This retrospective cohort study aimed to compare treatment success and retention between men and women on a smoking cessation program (n=1,014) delivered at a CAPS-AD unit in Brazil. The psychological intervention lasted 6 weeks for each group of 15 patients. Each patient had to participate in weekly group cognitive-behavioral therapy (CBT) sessions and individual medical appointments during this period. These appointments were focused on the possibility of prescribing pharmacological treatment (i.e., nicotine replacement therapy, bupropion, or nortriptyline) as adjuvants to group therapy.Results: The women had lower smoking severity at baseline, more clinical symptoms, and lower prevalence of alcohol and drug use disorders and were older than the men. Females had significantly higher levels of success (36.6% vs. 29.7%) and retention (51.6% vs. 41.4%) than males. Sensitivity analysis showed that female gender was significantly associated with both retention and success, among those without drug use disorders only.Conclusion: Depending on the smoking cessation setting (i.e., low and middle-income countries and mental health and addiction care units), females can achieve similar and even higher quit rates than males. Previous drug use disorder was an important confounding variable in the gender outcomes analyses. Future studies should try to replicate these positive smoking cessation effects of CBT-based group therapy plus pharmacotherapy in women.
Palavras-chave
Tobacco use cessation, female, tobacco use disorder
Referências
- Allen SS, 2009, ADDICT BEHAV, V34, P107, DOI 10.1016/j.addbeh.2008.08.009
- Bold KW, 2015, ANN BEHAV MED, V49, P128, DOI 10.1007/s12160-014-9627-6
- Brasil. Ministerio da Saude (MS), 2020, VIG BRAS 2019 VIG FA
- Campbell BK, 2016, AM J DRUG ALCOHOL AB, V42, P649, DOI 10.1080/00952990.2016.1183021
- Castaldelli-Maia JM, 2021, BRAZ J PSYCHIAT, V43, P75, DOI 10.1590/1516-4446-2019-0782
- Castaldelli-Maia JM, 2018, PSYCHOL ADDICT BEHAV, V32, P415, DOI 10.1037/adb0000369
- Castaldelli-Maia JM, 2018, EUR PSYCHIAT, V52, P22, DOI 10.1016/j.eurpsy.2018.02.005
- Castaldelli-Maia JM, 2018, PSYCHIAT RES, V266, P275, DOI 10.1016/j.psychres.2018.03.018
- Castellani V, 2020, REV ASSOC MED BRAS, V66, P146, DOI 10.1590/1806-9282.66.2.146
- Cepeda-Benito A, 2004, J CONSULT CLIN PSYCH, V72, P712, DOI 10.1037/0022-006X.72.4.712
- Chatkin JM, 2006, INT J TUBERC LUNG D, V10, P499
- Christofferson DE, 2021, NICOTINE TOB RES, V23, P931, DOI 10.1093/ntr/ntaa183
- Collins BN, 2004, NICOTINE TOB RES, V6, P27, DOI 10.1080/14622200310001656830
- Drope J., 2018, TOBACCO ATLAS
- Evans-Polce RJ, 2015, SOC SCI MED, V145, P26, DOI 10.1016/j.socscimed.2015.09.026
- Greaves L, 2015, INT J ENV RES PUB HE, V12, P1449, DOI 10.3390/ijerph120201449
- Halperin AC, 2009, J SUBST ABUSE TREAT, V36, P428, DOI 10.1016/j.jsat.2008.09.001
- Huang Y, 2013, TOB CONTROL, V22, P274, DOI 10.1136/tobaccocontrol-2011-050124
- Husky MM, 2007, J ADDICT MED, V1, P161, DOI 10.1097/ADM.0b013e318142d06c
- Instituto Brasileiro de Geografia e Estatistica. [IBGE], 2015, PESQUISA NACL AMOSTR
- Jarvis MJ, 2013, TOB CONTROL, V22, P356, DOI 10.1136/tobaccocontrol-2011-050279
- Lancaster T., 2017, COCHRANE DB SYST REV, V3, DOI [10.1002/14651858.CD001292.pub3, DOI 10.1002/14651858.CD001292.PUB3]
- Lima DR, 2020, J PSYCHIATR RES, V125, P121, DOI 10.1016/j.jpsychires.2020.03.014
- Loreto AR, 2017, J DUAL DIAGN, V13, P238, DOI 10.1080/15504263.2017.1328149
- Martinez-Vispo C, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17124317
- Pegington M, 2020, OBES REV, V21, DOI 10.1111/obr.13002
- Perkins KA, 2013, ADDICT BEHAV, V38, P1527, DOI 10.1016/j.addbeh.2012.06.002
- Quisenberry AJ, 2019, DRUG ALCOHOL DEPEN, V202, P93, DOI 10.1016/j.drugalcdep.2019.07.001
- Lombardi EMS, 2011, J BRAS PNEUMOL, V37, P118, DOI 10.1590/S1806-37132011000100017
- Smith PH, 2016, PREV MED, V92, P135, DOI 10.1016/j.ypmed.2016.07.013
- Smith PH, 2015, NICOTINE TOB RES, V17, P463, DOI 10.1093/ntr/ntu212
- Smith PH, 2014, DRUG ALCOHOL DEPEN, V142, P333, DOI 10.1016/j.drugalcdep.2014.07.003
- Smith SS, 2009, ARCH INTERN MED, V169, P2148, DOI 10.1001/archinternmed.2009.426
- Stead LF, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001007.pub3
- Stead LF, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008286.pub3
- Steinberg MB, 2006, AM J PREV MED, V30, P405, DOI 10.1016/j.amepre.2005.12.008
- Tong VT, 2013, MMWR SURVEILL SUMM, V62, P1
- Torchalla I, 2011, J SMOK CESS, V6, P9, DOI 10.1375/jsc.6.1.9
- Waters AF, 2018, ADDICT BEHAV, V84, P99, DOI 10.1016/j.addbeh.2018.03.018
- Wray JM, 2018, NICOTINE TOB RES, V20, P1418, DOI 10.1093/ntr/ntx212